Retina specialists examine evolving role of laser therapy in DME treatment
Laser photocoagulation has long been a mainstay in the treatment of diabetic macular edema associated with diabetic retinopathy, but some retina specialists believe adjunctive use of laser may increase durability of commonly used anti-VEGF agents.
Before anti-VEGFs became the go-to treatment for DME, laser therapy was the norm, according to David M. Brown, MD, FACS.
“The treatment before anti-VEGF was all laser,” Brown said in the cover story of the latest issue of Ocular Surgery News. “However, the gains seen in RISE/RIDE (ranibizumab), VISTA/VIVID (aflibercept) and the DRCR protocols (ranibizumab, aflibercept and bevacizumab) are all superior to anything seen with historical laser trials.”